Over the past three months, Oncorus Inc. [ONCR] ended the trading day at $26.50 and exhibited a change of 1.92% with a 24 hour trading and reached upto the volume of 120.35K compared to its recorded trading volume of 0.21 million. ONCR generated a 1 year amount change with N/A. Though for Principal markets a year is counted as a long time period. By having a look at the most recent performance of this stock, in the last week its amount moved by 18.18% with an amount shift of 73.33% over the last month.
On 12, November 2020, Oncorus to Present at Upcoming Jefferies Virtual London Healthcare Conference. According to news published on Yahoo Finance, Oncorus, Inc. (Nasdaq:ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, announced today that Theodore (Ted) A. Asbhurn, M.D., Ph.D., President and Chief Executive Officer, will present at the upcoming Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020 at 3:50 pm GMT (10:50 am ET).
Analyst Birdseye View:
The most recent analyst activity for Oncorus Inc. [NASDAQ:ONCR] stock was on October 27, 2020, when it was Initiated with a Buy rating from Jefferies, which also raised its 12-month price target on the stock to $22. Before that, on October 27, 2020, Piper Sandler Recapitulated an Overweight rating and elevated its amount target to $40. On October 27, 2020, Evercore ISI Initiated an Outperform rating and boosted its price target on this stock to $35.
In the past 52 weeks of trading, this stock has oscillated between a low of $14.60 and a peak of $26.69. Right now, according to Wall Street analyst the average 12-month amount target is $35.33. At the most recent market close, shares of Oncorus Inc. [NASDAQ:ONCR] were valued at $26.50. According to the average price forecast, investors can expect a potential return of -0.94%.
If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 4.24 and the whole liability to whole assets at 3.69. It shows enduring liability to the whole principal at 4.24 and enduring liability to assets at 0.04 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 25.18 points at 1st support level, the second support level is making up to 24.35. But as of 1st resistance point, this stock is sitting at 26.65 and at 27.29 for 2nd resistance point.
Oncorus Inc. [ONCR] reported its earnings at -$21.73 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.94/share signifying the difference of -20.79 and -2,211.70% surprise value.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Oncorus Inc. [NASDAQ:ONCR] is 5.00. Likewise, the Quick ratio is also the same, showing Cash ratio at 9.17.
The most recent insider trade was by Flynn James E, Director, and it was the purchase of 1.0 million shares on Oct 06. MPM SunStates Fund, L.P., the 10% Owner, completed a purchase of 0.17 million shares on Oct 06. On Oct 06, MPM BioVentures 2014, L.P., 10% Owner, completed a purchase of 0.17 million shares.